Incyte's JAK cream Opzelura picks up steam as company works to revive Jakafi XR dreams
With Incyte's bread-and-butter Jakafi approaches a 2028 patent cliff, its topical counterpart Opzelura is gaining momentum as several expansion opportunities take shape.
